NCT04669886 Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
| NCT ID | NCT04669886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Nephrolithiasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2023-11-01 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.
Eligibility Criteria
Inclusion Criteria: * Adults that is able to consent (≥ 18 years of age) * Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals * not currently immunosuppressed \[White blood count (WBC) \>= 2, not on immunosuppressive medications\] Exclusion Criteria: * unable to consent and \< 18 years of age * currently immunosuppressed (WBC \< 2, not on immunosuppressive medications)
Contact & Investigator
Hemendra N Shah
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT04669886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nephrolithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04669886 currently recruiting?
Yes, NCT04669886 is actively recruiting participants. Contact the research team at hns35@miami.edu for enrollment information.
Where is the NCT04669886 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT04669886 clinical trial?
NCT04669886 is sponsored by University of Miami. The principal investigator is Hemendra N Shah at University of Miami. The trial plans to enroll 150 participants.